WallStSmart

Beamr Imaging Ltd. Ordinary Share (BMR)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Zepp Health Corp generates 8268% more annual revenue ($258.90M vs $3.09M). ZEPP leads profitability with a -15.5% profit margin vs -194.6%. ZEPP earns a higher WallStSmart Score of 41/100 (D).

BMR

Avoid

18

out of 100

Grade: F

Growth: 3.3Profit: 2.0Value: 4.0Quality: 5.0

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

BMRSignificantly Overvalued (-84.8%)

Margin of Safety

-84.8%

Fair Value

$0.92

Current Price

$1.94

$1.02 premium

UndervaluedFair: $0.92Overvalued
ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BMR1 strengths · Avg: 8.0/10
Price/BookValuation
1.9x8/10

Reasonable price relative to book value

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

BMR4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$30.44M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-32.7%2/10

ROE of -32.7% — below average capital efficiency

Revenue GrowthGrowth
-1.8%2/10

Revenue declined 1.8%

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : BMR

The strongest argument for BMR centers on Price/Book.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : BMR

The primary concerns for BMR are EPS Growth, Market Cap, Return on Equity.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

BMR profiles as a turnaround stock while ZEPP is a hypergrowth play — different risk/reward profiles.

BMR carries more volatility with a beta of 3.83 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor SOFTWARE - APPLICATION industry trends, competitive dynamics, and regulatory changes.

Bottom Line

ZEPP scores higher overall (41/100 vs 18/100) and 43.0% revenue growth. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Beamr Imaging Ltd. Ordinary Share

TECHNOLOGY · SOFTWARE - APPLICATION · USA

Beamr Imaging Ltd. (BMR) is an innovative technology leader in video optimization and image compression, dedicated to enhancing the performance and efficiency of streaming services and content delivery networks. Utilizing its proprietary algorithms, the company allows broadcasters and content creators to deliver superior video quality while significantly lowering bandwidth expenses. With the growing demand for high-resolution content, Beamr's cutting-edge solutions and collaborative spirit position it as an essential ally for businesses striving to boost viewer engagement and competitiveness in the dynamic digital media industry.

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?